T 2094/13 (Treatment of amyloidogenic diseases/JANSSEN) of 12.05.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T209413.20160512
- Date of decision
- 12 May 2016
- Case number
- T 2094/13
- Petition for review of
- -
- Application number
- 08011409.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Prevention and treatment of amyloidogenic disease
- Applicant name
- Janssen Alzheimer Immunotherapy
- Opponent name
- F. Hoffmann-La Roche
Eli Lilly and Company
Biogen Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2)European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Sufficiency of disclosure - all claim requests (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed